The recommended frequency for use in both Alpha-Stim® Cranial Electrotherapy Stimulation (CES):
Neuroimaging studies, such as qEEG and fMRI, have shown Alpha-Stim CES to:
It is never recommended to perform a CES session while:
In the United States, cranial electrotherapy stimulation (CES) is cleared for:
How do patients most commonly report feeling after a session of Alpha-Stim CES?
After speaking with Mrs. Jay, you prescribe Cranial Electrotherapy Stimulation (CES). During the last 5 minutes of a 20-minute treatment session, she reports feeling “heavy”, “groggy”, and “disoriented”. Based on these symptoms, what next steps should you take?
Mr. Kay initially sought treatment for insomnia and you prescribed Cranial Electrotherapy Stimulation (CES) daily. During his two-week follow up appointment, Mr. Kay complains that his insomnia is not improving. How will you advise the patient?
Contraindication(s) for use of Alpha-Stim CES is/are:
During a follow up appointment with a patient for which you prescribed Cranial Electrotherapy Stimulation (CES), the patient complains of having headaches, vertigo, and nausea when they use their CES. The symptoms appear after they start the session and remain for several hours following treatment. How do you advise the patient?
Which of the following is true regarding Alpha-Stim CES treatment?
What is the protocol for determining the current level for an Alpha-Stim CES treatment session?
Which of the following are possible side effects to Alpha-Stim CES treatment?